3 Stocks on Our Radar This Week

TL;DR

Analysts discuss Modine Manufacturing, Starbucks, and Celgene, highlighting growth potential and challenges.

Transcript

Chris Hill: We're going to go to our man, Steve Broido, on the other side of the glass for stocks on our radar, and he'll hit you with a question. Also on the other side of the glass this week, long-time listener Harry Yang visiting us from the great state of Wisconsin. Thank you, Harry, for stopping by. Ron Gross, you're up first. Steve Broido's g... Read More

Key Insights

• ❤️‍🩹 Modine Manufacturing shows growth potential despite challenging end markets.
• 🤩 Starbucks targets overseas growth and revenue per store as key metrics for success.
• ❓ Celgene's patent protection secures profitability in the biotech industry.
• 💇 Cost-cutting measures and product pipelines drive strategic decisions for these companies.
• ❓ Analysts compare stock multiples, earnings growth, and market positioning in their evaluations.
• ❓ Stock analysis discussions highlight unique market conditions and growth strategies for different industries.
• 🌍 Focus on international expansion and market penetration influences stock performance for Starbucks.

Questions & Answers

Q: How does Modine Manufacturing tackle market challenges?

Modine Manufacturing is cutting costs, maintaining a strong balance sheet, and adapting to tough market conditions to ensure lean operations for future growth.

Q: Why should investors care about Starbucks even if they don't drink coffee?

Starbucks offers potential for growth with a focus on expanding store count and revenue per store in key markets like China, appealing to millions of coffee drinkers globally.

Q: What is the significance of patent protection for Celgene's drugs?

Patent protection is crucial for Celgene, ensuring profits to recoup research investments and maintain margins, as generics threaten profitability post-patent expiration.

Q: Which stock stands out as the preferred choice among analysts?

Analysts show a preference for Modine Manufacturing due to its potential upside and strategic cost-cutting efforts, aligning with a positive outlook on growth prospects.

Summary & Key Takeaways

• Ron Gross discusses Modine Manufacturing as a micro-cap with upside potential due to cost-cutting efforts.

• Matt Argersinger analyzes Starbucks, highlighting overseas growth and watchlist status for Million Dollar Portfolio.

• Jeff Fischer talks about Celgene's biotech market dominance, patent protection, and product pipeline.